CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Provided By GlobeNewswire

Last update: May 15, 2025

KUALA LUMPUR, MALAYSIA, May 15, 2025 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines, today announced its first quarter financial results and provided a business update.

Read more at globenewswire.com

CYCLACEL PHARMACEUTICALS - CYCC 6 PERP

NASDAQ:CYCCP (7/18/2025, 8:00:01 PM)

After market: 5.12 -0.37 (-6.78%)

5.4923

+0.18 (+3.43%)

CYCCP Overview

CYCCP Technical Analysis Report

CYCCP Fundamental Analysis Report

CYCLACEL PHARMACEUTICALS INC

NASDAQ:CYCC (7/18/2025, 8:00:01 PM)

After market: 12.13 -0.94 (-7.19%)